Global Pediatric Genetic Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Pediatric Genetic Testing Market Research Report 2024
Genetic testing within the newborns, infants, and adolescents is performed to identify the cause of developmental delay, multiple malformations, intellectual disability, and dysmorphic features, among others. The genetic tests are also used to rule out chromosomal abnormalities and single genes via various molecular and cytogenetic genetic techniques. These tests further can help the parents understand the reason behind the disorders and also manage the disease at an early stage.
According to MRAResearch’s new survey, global Pediatric Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Genetic Testing market research.
Key companies engaged in the Pediatric Genetic Testing industry include Quest Diagnostics, Centogene AG, Opko Health, Inc, Eurofins Scientific, Abbott Laboratories, Invitae Corporation, Fulgent Genetics, Agilent Technologies, Inc and PerkinElmer, Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Pediatric Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pediatric Genetic Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pediatric Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Quest Diagnostics
Centogene AG
Opko Health, Inc
Eurofins Scientific
Abbott Laboratories
Invitae Corporation
Fulgent Genetics
Agilent Technologies, Inc
PerkinElmer, Inc
Thermofisher Scientific
Genomic Diagnostics
Unilabs
LifeCell International Pvt. Ltd.
Trivitron Healthcare
Baebies, Inc
Segment by Type
Kits
LDT Tests
Reagents
Academic and Research
Clinical Diagnostics
Drug Discovery
Monitoring and Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pediatric Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Pediatric Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Genetic Testing market research.
Key companies engaged in the Pediatric Genetic Testing industry include Quest Diagnostics, Centogene AG, Opko Health, Inc, Eurofins Scientific, Abbott Laboratories, Invitae Corporation, Fulgent Genetics, Agilent Technologies, Inc and PerkinElmer, Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Pediatric Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pediatric Genetic Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pediatric Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Quest Diagnostics
Centogene AG
Opko Health, Inc
Eurofins Scientific
Abbott Laboratories
Invitae Corporation
Fulgent Genetics
Agilent Technologies, Inc
PerkinElmer, Inc
Thermofisher Scientific
Genomic Diagnostics
Unilabs
LifeCell International Pvt. Ltd.
Trivitron Healthcare
Baebies, Inc
Segment by Type
Kits
LDT Tests
Reagents
Segment by Application
Academic and Research
Clinical Diagnostics
Drug Discovery
Monitoring and Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pediatric Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source